Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Simvastatin improves mitochondrial respiration in peripheral blood cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Tumor cell MT1-MMP is dispensable for osteosarcoma tumor growth, bone degradation and lung metastasis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. An alternate conformation of HCV E2 neutralizing face as an additional vaccine target

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

There is a large unmet need for a prophylactic hepatitis C virus (HCV) vaccine to control the ongoing epidemic with this deadly pathogen. Many antiviral vaccines employ whole viruses as antigens. For HCV, this approach became feasible following the development of infectious cell culture systems for virus production. However, the lack of efficient downstream processes (DSP) for HCV purification poses a roadblock for the development of a whole virus vaccine. Using cell culture-derived genotype 1a HCV we developed a scalable and efficient DSP train, employing commonly used clarification and ultrafiltration techniques, followed by two membrane-based chromatography steps. For virus capture, steric exclusion chromatography using cellulose membranes was established, resulting in a virtually complete virus recovery with > 99% protein and 84% DNA depletion. Virus polishing was achieved by sulphated cellulose membrane adsorbers with ~ 50% virus recovery and > 99% protein and 90% DNA depletion. Additional nuclease digestion resulted in 99% overall DNA depletion with final DNA concentrations of 2 ng/mL. Process results were comparable for cell culture-derived HCV of another major genotype (5a). This study provides proof-of-concept for establishment of an efficient and economically attractive DSP with potential application for production of an inactivated whole virus vaccine against HCV for human use.

Original languageEnglish
Article number16261
JournalScientific Reports
Volume10
Issue number1
Pages (from-to)16261
ISSN2045-2322
DOIs
Publication statusPublished - 1 Dec 2020

ID: 60979076